AP

Amaresh Patil Kannal

Active Director Director DIN 08548114
DIN 08548114 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Aug 2019
Shareholding value •••• Premium profile

About Amaresh Patil Kannal

Data last updated:

Amaresh Patil Kannal is a Director at Shivaparvathi Medical Services Private Limited (since 2019), Director at Bhramaramba Mallikarjuna Medical Services Private Limited (since 2022) and Director at Srisaila Mallikarjuna Medical Services Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹15.76 Cr; the largest is Shivaparvathi Medical Services Private Limited at ₹7.08 Cr (FY 2024).

DIN 08548114
Primary Designation Director
Industry Healthcare
First Appointment 29 Aug 2019
Oldest Company Age 8 yrs
Largest company Shivaparvathi Medical Services Private Limited · ₹7.08 Cr (FY 2024)
Combined revenue ₹15.76 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20192018₹7.08 Cr (FY 2024)Active
Director11 Jan 20222022₹5.63 Cr (FY 2025)Active
Director23 Jul 20212021₹1.90 Cr (FY 2025)Active
Director02 Feb 20222022₹1.16 Cr (FY 2025)Active
Director07 May 20242024Active

Directorship timeline

Open interactive timeline →
Srisaila Mallikarjuna Medical Services Private Limited
Bhramaramba Mallikarjuna Medical Services Private Limited
Bhramaramba Srisaila Mallikarjuna Medical Services Private Limited
Shivaparvathi Medical Services Private Limited
Premium access

Shareholding and investment profile for Amaresh Patil Kannal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amaresh Patil Kannal

Amaresh Patil Kannal currently holds 5 directorships: Shivaparvathi Medical Services Private Limited (Director, since 29 Aug 2019, revenue ₹7.08 Cr (FY 2024)); Bhramaramba Mallikarjuna Medical Services Private Limited (Director, since 11 Jan 2022, revenue ₹5.63 Cr (FY 2025)); Srisaila Mallikarjuna Medical Services Private Limited (Director, since 23 Jul 2021, revenue ₹1.90 Cr (FY 2025)); Bhramaramba Srisaila Mallikarjuna Medical Services Private Limited (Director, since 02 Feb 2022, revenue ₹1.16 Cr (FY 2025)); Eshana Medical Services Private Limited (Director, since 07 May 2024).

Amaresh Patil Kannal was first appointed on 29 Aug 2019 as Director at Shivaparvathi Medical Services Private Limited. The most recent appointment on record is 07 May 2024 at Eshana Medical Services Private Limited.

The 4 current companies of Amaresh Patil Kannal that report revenue have a combined latest revenue of ₹15.76 Cr: Shivaparvathi Medical Services Private Limited ₹7.08 Cr (FY 2024); Bhramaramba Mallikarjuna Medical Services Private Limited ₹5.63 Cr (FY 2025); Srisaila Mallikarjuna Medical Services Private Limited ₹1.90 Cr (FY 2025); Bhramaramba Srisaila Mallikarjuna Medical Services Private Limited ₹1.16 Cr (FY 2025).

The current boards of Amaresh Patil Kannal's companies include Basavaraj Singanal (Shivaparvathi Medical Services Private Limited), Mallikarjuna Mallanagowda Devareddy (Shivaparvathi Medical Services Private Limited), Rakesh Babu Kumbar (Shivaparvathi Medical Services Private Limited), Srinivasulu Sandireddy (Shivaparvathi Medical Services Private Limited), Swetha Gurram (Shivaparvathi Medical Services Private Limited), Yella Akarsh (Shivaparvathi Medical Services Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available